Both companies will primarily act as local premises for D.Med’s technical service business unit.
Meet us at the 54th ERA-EDTA, the world’s largest event for the medical sector in the field of dialysis, from June 3rd-6th 2017Read more
D.Med Medical Services GmbH gladly announces the purchase of the Turkish operations of Swedish Diaverum Group. With about 2,200 chronic patients served by close to 500 employees …
D.Med Healthcare GmbH & Co. KG and Changshan Pharmaceutical (Hongkong) Co. Ltd., 100% subsidiary of the stock-listed Chinese manufacturer of pharmaceutical products, Hebei Changshan Biomedical Pharmaceutical Co. Ltd. (Shenzhen Stock Exchange / SIN 300255:CH), announce the set-up of a joint venture aiming at the production and marketing of Heparin formulations
D.Med Medical Services GmbH enters into a partnership with India-based Biomed to form German Renal Care Private Limited (GRC)
With a goal to provide affordable dialysis services and training in India while adhering to German and international standards, D.Med Medical Services GmbH entered into a partnership with India-based (Pune) Biomed.Read more
In the course of our expansion strategy in Africa we gladly announce the opening of new D.Med Healthcare sales entities in Kenya, Mozambique and Zimbabwe which will enable us to be even closer to our regional customers and partners and open up new opportunities in these buzzing markets.
With the creation of the D.Sicco GmbH between D.Med Healthcare Germany AG and Sisco Ltd. from India, D.Med Healthcare has integrated the product range of one of the major suppliers of Latex and Silicon Catheters into its group of companies.Read more